Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E

被引:56
作者
Bland, FA
Lemberg, MK
McMichael, AJ
Martoglio, B
Braud, VM
机构
[1] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France
[2] John Radcliffe Hosp, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England
[3] ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland
关键词
D O I
10.1074/jbc.M305593200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nonclassical major histocompatibility complex class I molecule HLA-E acts as a ligand for CD94/NKG2 receptors on the surface of natural killer cells and a subset of T cells. HLA-E presents closely related nonameric peptide epitopes derived from the highly conserved signal sequences of classical major histocompatibility complex class I molecules as well as HLA-G. Their generation requires cleavage of the signal sequence by signal peptidase followed by the intramembrane-cleaving aspartic protease, signal peptide peptidase. In this study, we have assessed the subsequent proteolytic requirements leading to generation of the nonameric HLA-E peptide epitopes. We show that proteasome activity is required for further processing of the peptide generated by signal peptide peptidase. This constitutes the first example of capture of a naturally derived short peptide by the proteasome, producing a class I peptide ligand.
引用
收藏
页码:33747 / 33752
页数:6
相关论文
共 40 条
[1]  
Bai AL, 1997, J IMMUNOL, V159, P2139
[2]  
Benham AM, 1998, J IMMUNOL, V161, P83
[3]   Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules [J].
Binder, RJ ;
Blachere, NE ;
Srivastava, PK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17163-17171
[4]   Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis [J].
Borrego, F ;
Ulbrecht, M ;
Weiss, EH ;
Coligan, JE ;
Brooks, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :813-818
[5]   TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide [J].
Braud, VM ;
Allan, DSJ ;
Wilson, D ;
McMichael, AJ .
CURRENT BIOLOGY, 1998, 8 (01) :1-10
[6]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[7]   Improving stable transfection efficiency:: antioxidants dramatically improve the outgrowth of clones under dominant marker selection [J].
Brielmeier, M ;
Béchet, JM ;
Falk, MH ;
Pawlita, M ;
Polack, A ;
Bornkamm, GW .
NUCLEIC ACIDS RESEARCH, 1998, 26 (09) :2082-2085
[8]  
Brooks AG, 1999, J IMMUNOL, V162, P305
[9]   26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide [J].
Cascio, P ;
Hilton, C ;
Kisselev, AF ;
Rock, KL ;
Goldberg, AL .
EMBO JOURNAL, 2001, 20 (10) :2357-2366
[10]  
García P, 2002, EUR J IMMUNOL, V32, P936, DOI 10.1002/1521-4141(200204)32:4<936::AID-IMMU936>3.0.CO